Effect of Anti CD20 in Pemphigus Desease

• Status: Completed
• Trial end date: 2008-10-01

Summary

to treat in an open non comparative clinical study patients presenting pemphigus with corticodependance, corticoresistance and contre-indication to systemic steroids.

• Phase: Phase 2/Phase 3

Details

• Lead Sponsor: University Hospital, Rouen
• Treatments: Rituximab